Hormone Antagonists and Related Agents
- Hormone Antagonists and Related Agents
- Accession Number
- ATC Classification
Drug Drug Description Abarelix For palliative treatment of advanced prostate cancer. Aminoglutethimide An adrenocortical steroid synthesis inhibitor used in the treatment of Cushing's syndrome. Flutamide An antiandrogen used for locally confined stage B2-C and D-2 metastatic prostate carcinoma. Toremifene A first generation nonsteroidal selective estrogen receptor modulator used to treat certain breast cancers. Nilutamide An antineoplastic hormone used to treat prostate cancer. Tamoxifen A selective estrogen receptor modulator used to treat estrogen receptor positive breast cancer, reduce the risk of invasive breast cancer following surgery, or reduce the risk of breast cancer in high risk women. Fulvestrant An estrogen receptor antagonist used to treat HR+ breast cancer that may also be HER2-. Exemestane An aromatase inhibitor used to treat breast cancer in postmenopausal women after treatment with tamoxifen. Letrozole An aromatase inhibitor used to treat breast cancer in postmenopausal women. Bicalutamide An androgen receptor inhibitor used to treat Stage D2 metastatic carcinoma of the prostate. Anastrozole A competitive, selective, non-steroidal aromatase inhibitor used as adjuvant therapy for the treatment of hormone receptor-positive breast cancer in postmenopausal women. Abiraterone An antiandrogen used in the treatment of prostate cancer. Degarelix A GnRH receptor antagonist used in the management of advanced prostate cancer. Enzalutamide An androgen receptor inhibitor used to treat castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer. Formestane For the treatment of estrogen-receptor positive breast cancer in post-menopausal women. Vorozole Not Annotated Apalutamide An androgen receptor inhibitor used to treat non metastatic, castration resistant prostate cancer. Darolutamide An androgen receptor antagonist used for castration-resistant, non-metastatic prostate cancer and metastatic hormone-sensitive prostate cancer.
- Drugs & Drug Targets